Endothelial progenitor cells
A new key for endothelial dysfunction in migraine
Abstract
Objective:
We aimed to study endothelial function with biochemical and ultrasonographic markers and its relation with endothelial progenitor cells (EPCs) in patients with migraine.
Methods:
We performed a case-control study including 47 patients with episodic migraine (International Headache Society 2004 criteria) and 23 control subjects. We analyzed flow-mediated dilation (FMD) in the dominant brachial artery, calcitonin gene−related peptide (CGRP), and vascular endothelial growth factor (VEGF) levels by ELISA, nitric oxide stable metabolites (NOx) by high-performance liquid chromatography, and EPCs in peripheral blood samples, obtained during interictal periods (n = 47) and migraine attacks (n = 19). Frequency, severity, duration of attacks, and time of evolution of migraine were also recorded.
Results:
Patients with migraine showed lower numbers of EPCs than control subjects (9.4 ± 5.0 vs 17.9 ± 6.0 colony forming unit−endothelial cells [CFU-ECs]; p < 0.0001) and higher levels of CGRP (164.2 ± 139.1 vs 37.1 ± 38.5 pg/mL), VEGF (473.4 ± 398.7 vs 72.6 ± 56.6 pg/mL), and NOx (1225.2 ± 466.1 vs 671.9 ± 358.6 μM) (all p < 0.05). During attacks, higher levels for CGRP (298.2 ± 100.3 pg/mL) and NOx (1,656.8 ± 259.5 μM) and lower numbers of EPC (7.2 ± 3.2 CFU-ECs) were observed (all p < 0.05). No changes were found for FMD in interictal periods or during headache. In relation to clinical parameters, EPCs decreased with the time of evolution of migraine (r = −0.592; p < 0.0001).
Conclusions:
Patients with migraine show reduced numbers of EPCs and increased levels of CGRP, NOx, and VEGF than control subjects. Furthermore, EPC counts decrease as migraine progresses in time. These findings suggest altered endothelial function in patients with migraine.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
File (rodriquez.pdf)
- Download
- 234.51 KB
REFERENCES
1.
Rexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39: 287–324.
2.
Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
3.
Silva FA, Rueda-Clausen CF, Silva SY, et al. Endothelial function in patients with migraine during the interictal period. Headache 2007; 47: 45–51.
4.
Yetkin E, Ozisik H, Ozcan C, Aksoy Y, Turhan H. Decreased endothelium-dependent vasodilatation in patients with migraine: a new aspect to vascular pathophysiology of migraine. Coron Artery Dis 2006; 17: 29–33.
5.
Vernieri F, Moro L, Altamura C, et al. Patients with migraine with aura have increased flow mediated dilation. BMC Neurol 2010; 10: 18.
6.
George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006; 12: 331–335.
7.
Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70: 1510–1517.
8.
Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009; 72: 1864–1871.
9.
Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006; 296: 283–291.
10.
Uzar E, Evliyaoglu O, Toprak G, et al. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 2011; 12: 239–243.
11.
Lassen LH, Ashina M, Christiansen I, et al. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998; 18: 27–32.
12.
Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008; 70: 1304–1312.
13.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–676.
14.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24(suppl 1): 9–160.
15.
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001; 41: 646–657.
16.
Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–265.
17.
Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelial and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 7–17.
18.
Sobrino T, Hurtado O, Moro MA, et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38: 2759–2764.
19.
Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151–153.
20.
Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
21.
Tsikas D, Rossa S, Sandmann J, Frölich JC. High-performance liquid chromatographic analysis of nitrite and nitrate in human plasma as S-nitroso-N-acetylcysteine with ultraviolet absorbance detection. J Chromatogr B Biomed Sci Appl 1999; 724: 199–201.
22.
Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995; 15: 384–390.
23.
Vanmolkot FH, Van Bortel LM, De Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007; 68: 1563–1570.
24.
Yetkin E, Ozisik H, Ozcan C, Aksoy Y, Turhan H. Increased dilator response to nitrate and decreased flow-mediated dilatation in migraineurs. Headache 2007; 47: 104–110.
25.
Fidan I, Yüksel S, Ymir T, Irkeç C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006; 171: 184–188.
26.
De Hoon JN, Smits P, Troost J, Struijker-Boudier HA, Van Bortel LM. Forearm vascular response to nitric oxide and calcitonin gene-related peptide: comparison between migraine patients and control subjects. Cephalalgia 2006; 26: 56–63.
27.
Shukla R, Barthwal MK, Srivastava N, et al. Blood nitrite levels in patients with migraine during headache-free period. Headache 2001; 41: 475–481.
28.
Martelletti P, D'Alò S, Stirparo G, Rinaldi C, Cifone MG, Giacozazzo M. Modulation of nitric oxide synthase by nitric oxide donor compounds in migraine. Int J Clin Lab Res 1998; 28: 135–139.
29.
Mikirova NA, Jackson JA, Hunninghake R, et al. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med 2009; 7: 106.
30.
Michalak S, Wegrzyn D, Osztynowicz K, Kozubski W. The serum levels of proangiogenic factors in migraineurs during interictal period. Presented at the AAN 61st Annual Meeting; April 30, 2009; Seattle.
31.
Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964–3972.
32.
Perko D, Pretnar-Oblak J, Šabovic M, Zaletei M, Žvan B. Associations between cerebral and systemic endothelial function in migraine patients: a post-hoc study. BMC Neurol 2011; 11: 146.
33.
Yip HK, Chang LT, Chang WN, et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008; 39: 69–74.
34.
Chu K, Jung KH, Lee ST, et al. Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 2008; 39: 1441–1447.
Information & Authors
Information
Published In
Copyright
Copyright © 2012 by AAN Enterprises, Inc.
Publication History
Received: November 28, 2011
Accepted: March 19, 2012
Published online: July 18, 2012
Published in print: July 31, 2012
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
Authors
Author Contributions
R. Leira and J. Castillo conceived and designed the research, analyzed and interpreted the data, and handled funding and supervision. X. Rodríguez-Osorio and R. Leira drafted the manuscript. J. Castillo performed statistical analysis. T. Sobrino and F. Martínez helped to analyze and interpret the data and made critical revision to the manuscript for important intellectual content. T. Sobrino and D. Brea acquired, analyzed, and interpreted the biochemical and cellular data and supervised the work. X. Rodríguez-Osorio, F. Martínez, and R. Leira helped to acquire, analyze, and interpret the clinical ultrasonographic data.
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Associations between Cerebrovascular Function and the Expression of Genes Related to Endothelial Function in Hormonal Migraine, International Journal of Molecular Sciences, 25, 3, (1694), (2024).https://doi.org/10.3390/ijms25031694
- Pain from Internal Organs and Headache: The Challenge of Comorbidity, Diagnostics, 14, 16, (1750), (2024).https://doi.org/10.3390/diagnostics14161750
- Unravelling the role of beta-CGRP in inflammatory bowel disease and its potential role in gastrointestinal homeostasis, BMC Gastroenterology, 24, 1, (2024).https://doi.org/10.1186/s12876-024-03366-w
- Elevated cytokine levels in the central nervous system of cluster headache patients in bout and in remission, The Journal of Headache and Pain, 25, 1, (2024).https://doi.org/10.1186/s10194-024-01829-9
- Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience, The Journal of Headache and Pain, 25, 1, (2024).https://doi.org/10.1186/s10194-024-01769-4
- Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study, Headache: The Journal of Head and Face Pain, 64, 7, (849-858), (2024).https://doi.org/10.1111/head.14768
- CGRP: vom Neuropeptid zum therapeutischen Target (Hintergründe und Pathophysiologie), Fortschritte der Neurologie · Psychiatrie, 92, 07/08, (267-276), (2024).https://doi.org/10.1055/a-2331-0783
- Calcitonin gene-related peptide (CGRP) levels in peripheral blood in patients with idiopathic intracranial hypertension and migraine, Clinical Neurology and Neurosurgery, 237, (108136), (2024).https://doi.org/10.1016/j.clineuro.2024.108136
- A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine, Brain, Behavior, and Immunity, 118, (459-467), (2024).https://doi.org/10.1016/j.bbi.2024.03.019
- High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis, Advances in Nutrition, 15, 2, (100163), (2024).https://doi.org/10.1016/j.advnut.2023.100163
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.